Rodriguez-Colon Sol M, Mo Jingping, Duan Yinkang, Liu Jiahao, Caulfield Joanne E, Jin Xuejuan, Liao Duanping
Department of Public Health Sciences, The Pennsylvania State University College of Medicine, A210, 600 Centerview Dr, Hershey, PA 17033, USA.
Stroke. 2009 Jan;40(1):200-5. doi: 10.1161/STROKEAHA.108.523035. Epub 2008 Oct 16.
Little is known about the metabolic syndrome (MetS) and the risk of incident stroke. This study is designed to identify particular clusters of MetS components that carry the highest risk of incident stroke.
We analyzed the public use data from the population-based Atherosclerosis Risk in Communities study. At baseline, 14 993 stroke-free middle-aged individuals were followed-up over 9 years for incident stroke. MetS components were defined according to the National Heart, Lung, and Blood Institute/American Heart Association criteria. Incident stroke was identified using a standardized incident events identification and classification protocol. Proportional hazard models were used to assess the RRs and 95% CIs of ischemic stroke associated with MetS and its different clusters.
At baseline, the prevalence of MetS was 39%. The mean age was 54, with 26% blacks and 55% females. The hazard ratio of incident ischemic stroke associated with MetS among women (hazard ratio, 2.41; 95% CI, 1.69 to 3.49) and men (hazard ratio, 2.11; 95% CI, 1.56-2.85) was similar. There was a dose-response relationship between the numbers of MetS components and the risk of incidence stroke. Persons with either elevated blood pressure or elevated fasting glucose in the clusters to form a MetS had the highest risk for incident stroke (hazard ratio, 2.74-4.16 comparing to the reference group) than MetS without these 2 components (hazard ratio, </=2.00 comparing to the reference group).
The data support the need to target MetS, especially MetS, with these 2 highest risk components (elevated blood pressure or elevated fasting glucose) in the clusters.
关于代谢综合征(MetS)与卒中发病风险的了解甚少。本研究旨在确定携带最高卒中发病风险的特定MetS组分集群。
我们分析了基于人群的社区动脉粥样硬化风险研究中的公共使用数据。在基线时,对14993名无卒中的中年个体进行了9年的随访以观察卒中发病情况。MetS组分根据美国国立心肺血液研究所/美国心脏协会标准进行定义。使用标准化的发病事件识别与分类方案识别发病卒中。采用比例风险模型评估与MetS及其不同集群相关的缺血性卒中的相对风险(RRs)和95%置信区间(CIs)。
在基线时,MetS的患病率为39%。平均年龄为54岁,其中26%为黑人,55%为女性。女性(风险比,2.41;95%CI,1.69至ģ.49)和男性(风险比,2.11;95%CI,1.56 - 2.85)中与MetS相关的缺血性卒中发病风险比相似。MetS组分数量与卒中发病风险之间存在剂量反应关系。在形成MetS的集群中,患有高血压或空腹血糖升高的个体发生卒中的风险最高(与参考组相比,风险比为2.74 - 4.16),高于没有这两种组分(与参考组相比,风险比≤2.00)的MetS。
数据支持针对MetS进行干预的必要性,尤其是针对集群中具有这两种最高风险组分(高血压或空腹血糖升高)的MetS。